Skip to main content

#151505

Anti-p63 [BU5]

Cat. #151505

Anti-p63 [BU5]

Cat. #: 151505

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: p63

Class: Monoclonal

Application: IHC

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Roy Jefferis

Institute: University of Birmingham

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-p63 [BU5]
  • Research fields: Apoptosis and autophagy;Cancer;Cell biology;Genetics
  • Clone: BU5
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC
  • Description: p63 is a non-glycated type II transmembrane protein which is resident in the rough endoplasmic reticulum. While it is not exclusively expressed on plasma cells, the presence of p63 distinguishes plasma cells from other lymphoid cells because of their high secretory activity.
  • Immunogen: Plasmacytoid cell line RPMI 8226
  • Isotype: IgG2b
  • Myeloma used: P3/NS1/1-Ag4.1

Target Details

  • Target: p63
  • Target background: p63 is a non-glycated type II transmembrane protein which is resident in the rough endoplasmic reticulum. While it is not exclusively expressed on plasma cells, the presence of p63 distinguishes plasma cells from other lymphoid cells because of their high secretory activity.

Applications

  • Application: IHC

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: '-15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Banham et al. J. Clin Pathol. 1997:50:485-489. PMID: 9378814

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.